The Phase 3 Clinical Trial of Pomalidomide

The Phase 3 Clinical Trial of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma has opened at the Mater University Hospital/MIRT.

MIRT is the first site in the UK and Ireland to open.

« Back